[(125)I]SD-7015 reveals fine modalities of CB(1) cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's disease

Eitemau Tebyg

• The decrease of dopamine D(2)/D(3) receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB(1) cannabinoid receptors in Parkinson’s disease: A preliminary autoradiographic study with the selective dopamine D(2)/D(3) antagonist [(3)H]raclopride and the novel CB(1) inverse agonist [(125)I]SD7015
  gan: Farkas, Szabolcs, et al.
  Cyhoeddwyd: (2012)
• In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB(1) receptor antagonist radioligand [(125)I]SD7015 in CB(1) knock-out and wildtype mouse
  gan: Máthé, Domokos, et al.
  Cyhoeddwyd: (2013)
• Discovery and Labeling of High Affinity 3,4-Diarylpyrazolines as Candidate Radioligands for In Vivo Imaging of Cannabinoid Subtype-1 (CB(1)) Receptors
  gan: Donohue, Sean R., et al.
  Cyhoeddwyd: (2008)
• Synthesis and In Vitro Autoradiographic Evaluation of a Novel High-affinity Radioiodinated Ligand for Imaging Brain Cannabinoid Subtype-1 Receptors
  gan: Donohue, Sean R., et al.
  Cyhoeddwyd: (2009)
• Evaluation in Monkey of [(11)C]PipISB and [(18)F]PipISB as Candidate Radioligands for Imaging Brain Cannabinoid Type-1 (CB(1)) Receptors In Vivo
  gan: FINNEMA, SJOERD J., et al.
  Cyhoeddwyd: (2009)